Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age
Rupp, Richard
(PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
10/19/21
→
10/18/26
Funding
Merck Sharp and Cohme Corporation ( Award # ):
$17,750.00
View all
View less